Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 37, 2013 - Issue 4
133
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Molecular Spectrum of β-Thalassemia in Fujian Province, Southeastern China

, , , , , , , , , & show all
Pages 343-350 | Received 01 Oct 2012, Accepted 23 Jan 2013, Published online: 20 May 2013
 

Abstract

To provide basic information for β-thalassemia (β-thal) screening, genetic counseling and prenatal diagnosis (PND), we characterized β-thal mutations in Fujian Province, Southeastern China. A total of 16 different β-thal gene mutations were identified from 1058 patients. Of these, the IVS-II-654 (C>T) and codons 41/42 (–TCTT) were the most prevalent, accounting for 76.3% of the total mutations. Six gene mutations, IVS-I-1 (G>T), Cap +40 to +43 (–AAAC), codon 30 (A>G), +22 (G>A), codons 54–58 (–TTATGGGCAACCC) and the initiation codon (ATG>AGG) were characterized for the first time in the Fujian population. Furthermore, the following mutations, +22 (G >A), codon 36 (–C) and codon 30 (A>G), were identified for the first time in Chinese individuals. This was the first comprehensive mutation spectrum of β-thal mutations studied in Fujian Province, People’s Republic of China (PRC).

ACKNOWLEDGMENTS

We thank all the patients and research workers for their participation.

Declaration of Interest

This research was supported by grants from Key Project from Fujian Provincial Department of Science and Technology (2010Y0009), Fujian Provincial Department of Science and Technology (2012J01311), Fujian Medical Innovation Project (2009-CX-14; 2012-CX-9) and key Clinical Specialty Discipline Construction Program of Fujian (20121589), PRC. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.